Groowe Groowe / Newsroom / RVMD
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

RVMD News

Revolution Medicines, Inc. Common Stock

Erasca, Inc. (ERAS) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before August 10, 2026

accessnewswire.com
ERAS RVMD

Lost Money on Erasca, Inc. (ERAS)? Join Class Action Before August 10, 2026 - Contact Levi & Korsinsky

accessnewswire.com
ERAS RVMD

Join Class Action to Recover Losses From Erasca, Inc. (ERAS) - Contact Levi & Korsinsky Before August 10, 2026

accessnewswire.com
ERAS RVMD

Securities Class Action Lawsuit Filed Against Erasca, Inc. (ERAS) – Levi & Korsinsky Represents Shareholders

accessnewswire.com
ERAS RVMD

The Lustgarten Foundation Honors Pioneers in Pancreatic Cancer Research at Annual Inspiring Hope Gala

prnewswire.com
ERAS RVMD

ERAS ALERT: Securities Fraud Class Action Launched Against Erasca, Inc. - August 10, 2026 Deadline

accessnewswire.com
ERAS RVMD

Contact Levi & Korsinsky by August 10, 2026 to Join Class Action Against Erasca, Inc. (ERAS)

accessnewswire.com
ERAS RVMD

Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
ERAS RVMD

ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

accessnewswire.com
ERAS RVMD

Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion

globenewswire.com
RVMD MRNA SRPT